4//SEC Filing
Thompson Tamar 4
Accession 0001599901-24-000168
CIK 0001599901other
Filed
Oct 8, 8:00 PM ET
Accepted
Oct 9, 5:23 PM ET
Size
8.8 KB
Accession
0001599901-24-000168
Insider Transaction Report
Form 4
Thompson Tamar
Director
Transactions
- Exercise/Conversion
Common Stock
2024-10-07$27.63/sh+30,000$828,900→ 30,000 total - Sale
Common Stock
2024-10-07$44.98/sh−30,000$1,349,259→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-10-07−30,000→ 0 totalExercise: $27.63Exp: 2031-01-10→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $44.20 to $45.57. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The option was granted on January 11, 2021 and fully vested prior to the date of transactions described in this form.
Documents
Issuer
Avidity Biosciences, Inc.
CIK 0001599901
Entity typeother
Related Parties
1- filerCIK 0001839248
Filing Metadata
- Form type
- 4
- Filed
- Oct 8, 8:00 PM ET
- Accepted
- Oct 9, 5:23 PM ET
- Size
- 8.8 KB